Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-25 @ 9:18 PM
NCT ID:
NCT04223856
Group ID:
EG000
Title:
Enfortumab Vedotin + Pembrolizumab
Description:
Participants received enfortumab vedotin at 1.25 mg/kg as an IV infusion over approximately 30 minutes on Days 1 and 8 of each cycle, and pembrolizumab 200 mg as an IV infusion over approximately 30 minutes on Day 1 of each cycle, after completion of the enfortumab vedotin infusion. 1 cycle = 3 weeks.
Deaths Number Affected:
133
Deaths Number At Risk:
None
Serious Number Affected:
220
Serious Number At Risk:
440
Other Number Affected:
435
Other Number At Risk:
440
Study:
NCT04223856
Results Section:
NCT04223856
Adverse Events Module:
NCT04223856